ICAP’s founder and global director appears on The Threshold, the new podcast from Foreign Policy about the fight to end infectious diseases around the world and the innovations that could get us there.
In this episode, Dr. El-Sadr recounts the history of the global HIV response and the pioneering role of ICAP in developing a model to introduce HIV care and treatment to sub-Saharan Africa in the early years of the AIDS crisis in Africa. She goes on to discuss the importance of HIV prevention, the promise of the groundbreaking new drug for pre-exposure prophylaxis (PrEP), lenacapavir, and the indelible contributions the United States of America has made to the struggle to achieve a world without AIDS.
About ICAP
A major global health organization that has been improving public health in countries around the world for two decades, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia Mailman School of Public Health, ICAP has projects in more than 40 countries, working side-by-side with ministries of health and local governmental, non-governmental, academic, and community partners to confront some of the world’s greatest health challenges. Through evidence-informed programs, meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu
